Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.

Abstract

Peritoneal metastasis (PM) has traditionally been approached with therapeutic nihilism. The evolution of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) over the last two decades, however, has caused a paradigm shift in treatment for PM. This modality is rapidly gaining acceptance as standard of care for PM from various… (More)
DOI: 10.1002/jso.23749

3 Figures and Tables

Topics

  • Presentations referencing similar topics